Luis, B., Miguel, M., Pedro, D., David, I., Itziar, A., Ana, G., . . . José Antonio, F. (2021). Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients. J Transl Autoimmun.
シカゴスタイル引用形Luis, Buzon-Martín, et al. "Benefits of Early Aggressive Immunomodulatory Therapy (tocilizumab and Methylprednisolone) in COVID-19: Single Center Cohort Study of 685 Patients." J Transl Autoimmun 2021.
MLA引用形式Luis, Buzon-Martín, et al. "Benefits of Early Aggressive Immunomodulatory Therapy (tocilizumab and Methylprednisolone) in COVID-19: Single Center Cohort Study of 685 Patients." J Transl Autoimmun 2021.
警告: この引用は必ずしも正確ではありません.